Migraine - Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 01-Jan-2017
No. of pages: 100
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Migraine - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Migraine forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Migraine till 2023.

Key Coverage and Benefits

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Migraine market.

  • Identifying patient populations in the global "Migrainemarket to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Migraine therapeutics in each of the markets covered.

  • To understand the future market competition in the global Migraine therapeutics market and Insightful review of the key market drivers and barriers.

Scope

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.

  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.

  • It also provides Migraine for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

Migraine - Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Migraine overview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Migraine Market
Global Epidemiology of Migraine Forecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)
Market of Europe
Market of Germany (2013-2015)
Forecasted Market of Germany (2016-2023)
Market of United Kingdom (2013-2015)
Forecasted Market of United Kingdom (2016-2023)
Market of France (2013-2015)
Forecasted Market of France (2016-2023)
Market of Italy (2013-2015)
Forecasted Market of Italy (2016-2023)
Market of Spain (2013-2015)
Forecasted Market of Spain (2016-2023)
Market of Japan (2013-2015)
Forecasted Market of Japan (2016-2023)
Market of ROW (2013-2015)
Forecasted Market of ROW (2016-2023)
Appendix
Report Methodology
Consulting Services
Disclaimer
Report Purchase Options
About DelveInsight

List of Tables

Table 1: Drug Description
Table 2: Drug, Marketed Details United States (US)
Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
Table 4: Drug, Patent Details for US
Table 5: Migraine Drug Sales (USD Millions)-2023
Table 6: Global Epidemiology of Migraine (2013-2023)
Table 7: Migraine Global Market (USD Millions), (2013-2015)
Table 8: Migraine Global Market (USD Millions), (2016-2023)
Table 9: Migraine US Market (USD Millions), (2013-2015)
Table 10: Migraine US Market (USD Millions), (2016-2023)
Table 11: Migraine Germany Market (USD Millions), (2013-2015)
Table 12: Migraine Germany Market (USD Millions), (2016-2023)
Table 13: Migraine United Kingdom Market (USD Millions), (2013-2015)
Table 14: Migraine United Kingdom Market (USD Millions), (2016-2023)
Table 15: Migraine France Market (USD Millions), (2013-2015)
Table 16: Migraine France Market (USD Millions), (2016-2023)
Table 17: Migraine Italy Market (USD Millions), (2013-2015)
Table 18: Migraine Italy Market (USD Millions), (2016-2023)
Table 19: Migraine Spain Market (USD Millions), (2013-2015)
Table 20: Migraine Spain Market (USD Millions), (2016-2023)
Table 21: Migraine Japan Market (USD Millions), (2013-2015)
Table 22: Migraine Japan Market (USD Millions), (2016-2023)
Table 23: Migraine ROW Market (USD Millions), (2013-2015)
Table 24: Migraine ROW Market (USD Millions), (2016-2023)

List of Figures

Figure 1: Migraine Drug Sales (USD Millions)-2023
Figure 2: Global Epidemiology of Migraine (2013-2023)
Figure 3: Migraine Global Market (USD Millions), (2013-2015)
Figure 4: Migraine Global Market (USD Millions), (2016-2023)
Figure 5: Migraine US Market (USD Millions), (2013-2015)
Figure 6: Migraine US Market (USD Millions), (2016-2023)
Figure 7: Migraine Germany Market (USD Millions), (2013-2015)
Figure 8: Migraine Germany Market (USD Millions), (2016-2023)
Figure 9: Migraine United Kingdom Market (USD Millions), (2013-2015)
Figure 10: Migraine United Kingdom Market (USD Millions), (2016-2023)
Figure 11: Migraine France Market (USD Millions), (2013-2015)
Figure 12: Migraine France Market (USD Millions), (2016-2023)
Figure 13: Migraine Italy Market (USD Millions), (2013-2015)
Figure 14: Migraine Italy Market (USD Millions), (2016-2023)
Figure 15: Migraine Spain Market (USD Millions), (2013-2015)
Figure 16: Migraine Spain Market (USD Millions), (2016-2023)
Figure 17: Migraine Japan Market (USD Millions), (2013-2015)
Figure 18: Migraine Japan Market (USD Millions), (2015-2023)
Figure 19: Migraine ROW Market (USD Millions), (2013-2015)
Figure 20: Migraine ROW Market (USD Millions), (2016-2023)

  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Mild Cognitive Impairment - Pipeline Review, H1 2017
    Published: 11-Apr-2017        Price: US 2000 Onwards        Pages: 124
    Mild Cognitive Impairment - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mild Cognitive Impairment - Pipeline Review, H1 2017, provides an overview of the Mild Cognitive Impairment (Central Nervous System) pipeline landscape. Mild cognitive impairment (MCI) is a condition involving problems with cognitive function (such as thinking, knowing and remembering). MCI is an intermediate s......
  • Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H1 2017
    Published: 11-Apr-2017        Price: US 2000 Onwards        Pages: 95
    Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H1 2017, provides an overview of the Neuromyelitis Optica (Devic's Syndrome) (Central Nervous System) pipeline landscape. Neuromyelitis optica (NMO), also known as Devic's disease, is an uncommon neurological condition caused by disease or......
  • Epilepsy - Pipeline Review, H1 2017
    Published: 15-Mar-2017        Price: US 2000 Onwards        Pages: 382
    Epilepsy - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H1 2017, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape. Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the brain which causes seizures. This leads to brief disruptions of the senses and sho......
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2017
    Published: 15-Mar-2017        Price: US 2000 Onwards        Pages: 62
    Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Inflammatory Demyelinating Polyneuropathy - Pipeline Review, H1 2017, provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (Central Nervous System) pipeline landscape. Chronic inflammatory demyelinating polyneuropathy (CIDP) also called as chronic ......
  • Trigeminal Neuralgia - Pipeline Review, H1 2017
    Published: 15-Mar-2017        Price: US 2000 Onwards        Pages: 55
    Trigeminal Neuralgia - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Trigeminal Neuralgia - Pipeline Review, H1 2017, provides an overview of the Trigeminal Neuralgia (Central Nervous System) pipeline landscape. Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from face to brain. Symptoms include spontaneous attacks of pain o......
  • Nicotine Addiction - Pipeline Review, H1 2017
    Published: 15-Mar-2017        Price: US 2000 Onwards        Pages: 57
    Nicotine Addiction - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nicotine Addiction - Pipeline Review, H1 2017, provides an overview of the Nicotine Addiction (Central Nervous System) pipeline landscape. Nicotine addiction also called tobacco dependence is an addiction to tobacco products caused by the drug nicotine. Predisposing factors include age, depression, schizophrenia, post......
  • Encephalitis - Pipeline Review, H1 2017
    Published: 08-Mar-2017        Price: US 2000 Onwards        Pages: 38
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalitis - Pipeline Review, H1 2017, provides an overview of the Encephalitis (Central Nervous System) pipeline landscape.Encephalitis is an inflammation of the brain tissue. There are two main types of encephalitis: primary and secondary. Primary encephalitis occurs when a virus directly infects the brain and spinal cord. Secondary encephalitis occurs when an infection starts elsewhere in the body and the......
  • Cluster Headache Syndrome - Pipeline Review, H1 2017
    Published: 08-Mar-2017        Price: US 2000 Onwards        Pages: 37
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cluster Headache Syndrome - Pipeline Review, H1 2017, provides an overview of the Cluster Headache Syndrome (Central Nervous System) pipeline landscape.Cluster headache is pain that occurs along one side of the head. It is frequently occurs around, behind, or above the eye. Symptoms include burning, sharp, steady pain, red eye, runny nose, excessive tearing and flushed face. Risk factors include age and gender......
  • Drug Addiction - Pipeline Review, H1 2017
    Published: 08-Mar-2017        Price: US 2000 Onwards        Pages: 165
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape.Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs